The Unflinching Hand at the Helm: Richard Pazdur's Enduring Legacy at the FDA
A New Dawn for Cancer Care: FDA Taps Veteran Scientist Richard Pazdur to Lead Groundbreaking Initiative
A Shifting Tide in Women's Health: FDA Eases Controversial Hormone Therapy Warning
A Quiet Recalibration: FDA Reconsiders Decades-Old Birth Control Warning
The Great Unburdening: Revisiting the Story of Menopause and Hormones
Unearthing a Quiet Oversight: The FDA's Bold Move to Reclaim Trust in Medicine
A Quiet Threat Lurks: Understanding the Urgent Fruit Recall
A New Dawn for Menopause Care: FDA Lifts Decades-Old Warning, Acknowledging Hope and Health
Whispers of Warning: Infant Botulism, a Formula Recall, and the Urgent Call for Parents
The FDA's Tightening Grip: A Crucible for Biotech's Biggest Bets
The Zynity Enigma: When Innovation Meets Intense Scrutiny at the FDA
The Tylenol Trials: When Courtrooms Clash with Hard Science
The Weight of Expectation: FDA, Obesity Drugs, and the Uneasy Dance Between Speed and Safety
Health Hype or Hazard? The Salmonella Outbreak Linked to Popular Greens Powder
The Pivotal Pill: How the Supreme Court's Mifepristone Ruling Could Reshape America's Healthcare Landscape
The Unexpected Ingredient: Sam's Club Recalls Supplements Over Salmonella Scare
The Fluoride Rethink: Why the FDA Is Pushing Back on Kids' Supplements
Project Optimus: A Risky Gamble? Unpacking the FDA's New Approach to Cancer Drug Approval
The Fluoride Question: Why the FDA Just Shifted Gears on Kids' Supplements
A Sweeping Change for Little Smiles: Why the FDA Just Banned Unapproved Fluoride for Kids
The Hidden Danger in Your Deli Salad: How a Common Dish Led to a Tragic Outbreak
Unlocking Affordability: The FDA's Bold Play to Turbocharge Generic Drug Access
A Shadow in the Supper: Recalled Pasta Meals Spark Growing Fears as Listeria Claims More Lives
The Unsettling Truth: A Common Blood Pressure Drug, a Cancer Risk, and the FDA's Swift Action
The Unsettling Truth: Another Blood Pressure Drug Recalled Over Cancer Concerns
When Your Medicine Turns Sour: The Troubling Saga of Tainted Blood Pressure Drugs
The Astonishing Disparity: Why Miebo's Price Tag is a World Apart Across the Atlantic
A Whisper Becomes a Roar: Unpacking the Turmoil at FDA's Biologics Hub
A Breath, For Now: The Supreme Court's Unexpected Turn in the Mifepristone Saga
The Pill, The Court, and a Crucial Pause: Why Mifepristone Access Remains, For Now
The Silent Threat on Your Plate: A Listeria Outbreak Rattles the Prepared Meal Industry
A Silent Threat in Your Sushi: The Nationwide Recall You Need to Know About
Pune's Bitter Pill: Inside the Cracks of Illicit Cough Syrup Sales
The Quiet Revolution: How the FDA is Finally Taking Aim at Sky-High Drug Prices
The Quiet Revolution: How Federal Officials Are Fighting for Cheaper Biotech Drugs
Unlocking Access: The FDA's Bold Move to Fast-Track Life-Saving Biosimilars
A Shot in the Arm for Purple Biotech: Unpacking the Hype Around a Promising Cancer Drug
The Hidden Threat in Your Daily Dose: E. Coli Strikes a Popular Multi-Vitamin, Sparking Urgent Recall
The Nicotine Revolution? How One Company Just Cracked the Code (and Sent Its Stock Soaring)
The Shifting Pulse: Could Dr. Casey Means Reshape America's Health as Surgeon General?
The Unseen Threat: Why Your Makeup Remover Might Be Hiding Bacteria
A Stirring Concern: Why Your Pantry's Barilla Pasta Might Be Hiding a Serious Allergy Risk